Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Tucidinostat Plus PD-1 Inhibitor and Bevacizumab for Advanced Esophagus Cancer, AEG, Gastric Cancer (NCT05163483) | Ruihua Xu | 2022-07-01 |
Track Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.